Diagnostic mouthpieces

Abstract

Diagnostic mouthpieces and separate pads for same allow dental devices of various types to have a dual purpose. The diagnostic mouthpieces allow frequent use and early intervention.

Claims

1. A diagnostic pad for oral use, said diagnostic pad comprising: i) an absorbent material in a U-shape for contacting occlusal surfaces of dentition; ii) said absorbent material comprising at least two diagnostic indicators comprising antibodies for testing at least two salivary markers or biomarkers; iii) a transparent flexible waterproof coating on three sides of said absorbent material, leaving one edge open for saliva ingress; and iv) an adhesive backing on an outer surface of said coating, said adhesive backing covered with a removable protective layer.

2. A diagnostic pad for oral use, said diagnostic pad comprising: i) an absorbent material in a U-shape for contacting occlusal surfaces of dentition; ii) said absorbent material comprising at least two diagnostic indicators comprising antibodies for testing at least two salivary markers or biomarkers; iii) a transparent flexible waterproof coating on three sides, leaving one edge open for saliva ingress, iv) at least one lateral flow immunological test on said diagnostic pad; and v) an adhesive backing on an outer bottom surface of said waterproof coating, said adhesive backing covered with a removable protective layer.

3. A diagnostic pad for oral use, said diagnostic pad comprising: a) an absorbent material in a rectangular strip having two ends; b) said absorbent material comprising at least two diagnostic indicators comprising antibodies for testing at least two salivary markers or biomarkers; c) said absorbent material comprising a transparent flexible waterproof coating, leaving at least one open surface for saliva ingress; d) said waterproof coating having an adhesive backing on an outer surface, said adhesive backing covered with a removable protective layer; and e) having two open edges at each of said two ends, and having a lateral flow immunological test at each of said two ends.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) FIGS. 1A-B show standard dental nomenclature, which is employed herein. The central and lateral incisors and the cuspids are also known as anterior teeth, while the premolars and molars are posterior.

(2) FIG. 2 shows a prior art lateral flow test strip. This design can be adapted for use in the invention, as shown in FIG. 4A-B.

(3) FIG. 3 shows a U-shaped diagnostic pad having a waterproof outer coating, wherein the end edges are open in 3A for saliva ingress, but the inner edge is open in 3B.

(4) FIGS. 4A-B show top views of two diagnostic indicator pads that can be used with various mouthpieces, wherein the placement pattern of diagnostic indicators is varied.

(5) FIG. 5A shows a perspective view of a mouthpiece with open inner edge, into which a diagnostic indicator pad can be fitted. Although an inner core is not shown in this simple version, a mouthpiece with inner core and connector can be made in a similar way.

(6) FIG. 5B shows a cross section of the mouthpiece of FIG. 5A, wherein the upper layer of the mouthpiece is spread apart from the lower layer, such that a diagnostic indicator pad can be inserted thereinto.

(7) FIG. 5C shows the same cross section, wherein the mouthpiece is closed via some closing mechanism, herein shown a snap fitting connector.

(8) FIGS. 6A-E show an exemplary AcceleDent mouthpiece A, the inner core B and connector details C-E.

(9) FIG. 7 salivary test kits, available from Salimetrics.

(10) FIG. 8 salivary biomarkers, from Soo (2007).

(11) FIGS. 9A-C display various salivary markers, from Rathnayake (2013).

(12) FIG. 10 displays various pH indicator dyes that can be used with the invention.

(13) FIG. 11 salivary biomarkers and known ranges as a percentage of total protein, from Ruhl (2012).

(14) FIG. 12. Various markers known to be associated with oral disease, from Pederson (2005).

(15) FIG. 13. Importance of bacteria probes according to their individual discriminative power. Bacterial species or group are indicated along the y-axis. Shaded bars indicate the importance of the species as measured by the Wilcoxon rank-sum score (the score is calculated as log P, where P is the P value of the test). A larger importance indicates a larger propensity for the levels of that bacterial species or group to be differentially expressed in the caries-free versus the caries-active group. S. parasanguinis appears to be the most differentially expressed bacterial marker of caries, followed by Abiotrophia defective, from Hart (2011).

(16) FIG. 14. Relative importance of bacterial DNA probes for classifying caries-active and caries-free samples using the random forest model. The 25 most significant DNA probes are listed, and the shaded bars display their importance. The five most important probes are Actinomyces strain B19SC, Streptococcus mutans, Streptococcus parasanguinis, Selenomonas sp. Clone EY047, and Abiotrophia defective, from Hart (2011).

(17) FIG. 15. Wide but shallow gliding scale of variables related to caries. Schematic picture illustrating the ability of the PLS method to give the relative rank of associations for multiple variables. Displayed is the gliding scale of all plaque, saliva and diet (n=88) and previous caries (n=18) variables in the case of incidence (model M4); from the most influential (VIP>1.0) positively associated variables (top) to the most influential negatively associated variables (bottom). Some variables are marked by arrows and bold bars, from Nordlund (2009).

(18) FIG. 16 displays drugs of abuse and therapeutic drugs that are monitored in saliva, from Kaufman 2002.

DETAILED DESCRIPTION OF THE DISCLOSURE

(19) The invention can comprise one or more of the following embodiments, in any combination:

(20) TABLE-US-00001 A diagnostic mouthpiece for oral use, said mouthpiece comprising: a U-shaped bite plate to contact occlusal surfaces of a patient's teeth; said U-shaped bite plate comprising an absorbent material that is: a) on one or more surfaces thereof, or b) between two surfaces thereof with at least one edge accessible for saliva ingress; said absorbent material comprising diagnostic indicators specific for at least one salivary marker or salivary bio marker. The U-shaped bite plate comprising vertical edges to contact the facial surfaces of said patient's teeth. The U-shaped bite plate comprising vertical edges to contact both facial and lingual surfaces of a patient's teeth. The U-shaped bite plate having a connector protruding from a midline thereof, said connector for reversible coupling to an extra-oral orthodontic remodeling device. The extra-oral orthodontic remodeling device includes a water resistant housing containing a vibrator operably coupled to a power source operably coupled to a processor for controlling device usage. The processor also records and transmits compliance data. The vibrator vibrates at a selected frequency from 20 to 40 Hz and at a selected force from 0.1 to 0.5 Newtons. The vibrator vibrates at 30 Hz and 0.2 Newtons. The connector is a cylindrical post having a base end near said bite plate, said cylindrical post being 5.5 mm diameter and about 10.25 mm in length and having a groove circumnavigating said cylindrical post at 4 mm from said base end. A diagnostic pad for oral use, said diagnostic pad comprising an absorbent material in a U-shape for contacting occlusal surfaces of dentition, said absorbent material comprising at least two diagnostic indicators thereon, for testing at least two salivary markers or biomarkers. The diagnostic pad comprising a transparent flexible waterproof coating on three sides thereof, leaving one edge open for saliva ingress, and comprising at least one lateral flow immunological test. The diagnostic pad comprising a transparent flexible waterproof coating on three sides thereof, leaving one edge open for saliva ingress, and comprising at least 4 lateral flow immunological tests. The diagnostic pad comprising an adhesive backing on an outer bottom surface of said waterproof coating, said adhesive backing covered with a removable protective layer. A diagnostic pad for oral use, said diagnostic pad comprising: an absorbent material in a rectangular strip having two ends; said absorbent material comprising at least two diagnostic indicators thereon for testing at least two salivary markers or biomarkers; said absorbent material comprising a transparent flexible waterproof coating, leaving at least one open surface for saliva ingress; said waterproof coating having an adhesive backing on an outer surface thereof, said adhesive backing covered with a removable protective layer. The diagnostic pad having two open edges at each of said two ends, and having a lateral flow immunological test at each of said two ends.

(21) FIGS. 1A-B provides some general dental terminology, and is for reference use only. Standard dental and orthodontic nomenclature is used herein.

Lateral Flow Test Strips

(22) FIG. 2 shows a common design for a lateral flow test strip for a sandwich immunoassay, comprising a sample pad, a conjugate pad with detection conjugate, in this case gold-based conjugate, test and control lines, often on a membrane, such as nitrocellulose, followed by another absorbent pad for wicking.

(23) The sample pad is made of cellulose, glass fiber or other material where the fluid sample is applied to the lateral flow device and, if necessary, modifies it to improve the results of the assay. This might be by modifying pH, filtering out solid components, separating whole blood constituents, adsorbing out unwanted antibodies or some other test specific variable.

(24) The conjugate pad is made of a non-absorbent material such as fiberglass pad, polyester, rayon or a similar material. The conjugate pad is of a synthetic material (at least when using a gold conjugate) to ensure the efficient release of its contents.

(25) The detection conjugate, often a labeled antibody, is dried down and stays in place until a liquid test sample is applied to the sample pad. The liquid from the sample, by capillary action moves into the conjugate pad, re-hydrates the detection conjugate and allows the mixing of the sample with the conjugate. The complex of detection conjugate and analyte then moves into and up the membrane.

(26) The signal reagents used in lateral flow tests have become much more varied as the technology advances. Tests may use colloidal metals such as gold or silver, carbon, a visible or florescent dye, magnetic particles, enzymes, latex beads impregnated with visual or fluorescent dyes, or a combination of these which are conjugated to either an antibody or antigen to generate signal. In early versions of lateral flow tests, latex was a common conjugate, however colloidal gold is probably the most commonly used signal reagent in use today. The reagent used as a signal reagent will affect whether a strip can be simply read visually or if it will require an instrumented reader.

(27) The vast majority of the available assays contain gold, colored latex or another visually observable particle adsorbed with antibodies or antigens specific to the analyte being detected. If the strip will be read visually, the detection particle must be large enough to be seen but not so large as to overwhelm the antibody (or antigen) conjugated to its surface through steric hindrance. These particles usually run from 10-100 nm in diameter, but there can be exceptions.

(28) Conjugate is added to the pad usually by immersion or spraying. In immersion, the conjugate pad is submerged in the conjugate-protein suspension. In spraying, the pad is coated using quantitative, directional aerosol dispenser, which is somewhat similar to an inkjet printer. Spraying offers much more control of the conjugate application and prevents dilution and washing away of the pad pretreatment, but it also adds a significant capital expense and can increase the complexity of strip manufacturing.

(29) The nitrocellulose (NC) membrane consists of a very thin Mylar sheet coated with a layer of NC. The benefits of NC as an assay matrix are the reason why it so completely dominates the rapid test market. These benefits include low cost, capillary flow, high binding affinity for protein, ease of handling and cutting, as well as the ability of manufactures to varying thickness and components of the membrane to suit customer and market needs.

(30) As with many immunological based assays, blocking may be necessary to prevent nonspecific binding of sample and conjugate to the test lines and to limit background along the membrane. This is especially true with NC membranes. Blocking is also used to control flow rates and stabilize test and control-line proteins. The blocking process involves immersion of the striped membrane in an aqueous solution of proteins, surfactants, and/or polymers. The membrane is then removed, blotted, and dried.

(31) The detection conjugate/analyte complex then moves onto the membrane strip and migrates towards the capture binding protein, where it becomes immobilized and produces a distinct signal in the form of a sharp red line. A second line, a control, may also be formed on the membrane by excess detection conjugate, indicating the test is complete.

(32) The standard for lateral flow tests is one test line and one control line placed on the NC membrane. These are usually closer to the absorbent wicking pad than to the sample/conjugate pads. Lateral flow assays may have more than one test line, but each additional test line can increase cost.

(33) The absorbent pad, also called a wick or wicking pad, pulls fluid off of the membrane to allow the capillary flow of the membrane to keep flowing in the proper direction and at the proper rate. If an absorbent pad isn't used (or if it separates from the membrane so it is functionally absent), the sample and buffer will back flow down the membrane and could raise the background or possibly cause false positives. This can also occur if the absorbent pad selected for the volumes of buffer and sample involved is inadequate. Most absorbent pads are made from non-woven, cellulose fiber sheets. These pads can be manufactured in a variety of thicknesses and densities to suit the needs of the assay.

(34) Due to the delicate nature of the materials used in a lateral flow immunoassay as well as the need to maintain a precise, direct contact between components to ensure proper reagent and sample flow, a backing card of some sort is usually needed, although in this instance the bite plate can provide the needed support. Usually, these are pre-treated with a pressure-sensitive adhesive selected for its stability in the assay and to insure it doesn't leach chemicals that may interfere with results. A related concern is that the adhesive is strong enough to properly bind the materials to the card but that it also doesn't flow too far into them and inhibit the capillary action by reducing the available bed volume. The adhesive card is initially covered with a liner, which may be pre-slit for easier assembly of test components. The backing card can be modified for use in this invention to cover additional surfaces, and the same manufacturing issues apply, although adhesive can be limited to areas between tests.

(35) Many materials are available depending on the needs of the assay platform and manufacture configurations of the diagnostic tests. The more common materials are: polystyrene, vinyl, polyester (clear or opaque), and Mylar.

U-Shaped Diagnostic Pads

(36) As can be seen, in many embodiments, the bite plate is generally U-shaped, following the curve of the dentition. Preferably, the device is manufactured and sold in a Euro arch form, thus fitting the majority of North American and European patients, but a wider arch can also be made, so as to fit a majority of Asian patients, or the even wider Damon arch can be used.

(37) FIGS. 3A and B and FIGS. 4A and B show the waterproof coating 5 and diagnostic pad 7 of device 1. In 3A, the ends are open (e.g., not covered with a waterproof coating), so that saliva enters pad 7 via these open edges (see arrow), whereas the remaining surfaces are covered with coating 5. In FIG. 4A, a top view of the diagnostic pad is shown, wherein saliva ingress via the ends. At least two lateral flow tests (see antibody lines 2, 3, 4 as described in FIG. 2) can be fitted on this device 1, and it is possible that two tests can be fitted at each end, providing a 4-immunoassay device 1. Alternatively, one or more of the tests can be a spot test.

(38) FIG. 3B shows another embodiment of the bite plate 1 with a transparent outer coating 5 over diagnostic pad 7, wherein one of the ends of the bite plate is cut across to show a portion in cross section. In 3B the coating is open on the inner edge of the bite plate so that saliva can ingress at this edge (see arrow) into the pad 7. FIG. 4B shows a top view of such a bite plate 1. In this embodiment, many lateral flow (2, 3, 4) and spot tests are possible.

(39) FIG. 5A-C shows another variation, wherein the bite plate 11 can be opened and a new diagnostic pad 15 inserted thereinto. In FIG. 5A, 11 is the U-shaped mouthpiece, here shown as a simple flat U only, but can and probably would be more complex. Pad 15 is seen inside the bite plate, wherein one of the ends has been cut off to provide a cross sectional view, showing details of a post 16. The inner edge 13 is open, allowing for saliva ingress and closable posts 16 are shown.

(40) FIG. 5B shows a more detailed cross section, wherein post 16 is shown in an open position, bite plate 11 being of sufficiently flexible material to allow lifting of the inner edge 13 and insertion of pad 15. In FIG. 5C, the posts are snap fit closed into a small opening shaped for same in the receiving surface, but other attachment or closure means are possible.

Commercial Bite Plates

(41) FIG. 6A-E shows an exemplary bite plate for AcceleDent, which can be modified to include the diagnostic pad of the invention. In more detail, FIG. 6A shows a bite plate 1000, having generally U-shaped base 1001 that contacts occlusal surfaces of the teeth, the base having front and back edges, one or both edges having a rim to contact the facial and lingual surfaces of teeth and/or gums. Thus, upper lingual rim 1002, lower lingual rim 1003, upper facial rim 1005 and lower facial rim 1006 are shown. In 6A, the facial rims 1005/1006 contact only the incisors, canines and part of cuspids, but not premolars or molars, and thus the bite plate can also accommodate class II/III appliances. However, the facial and lingual rims can be varied in length to contact all, or a portion, of the teeth surfaces, as needed for particular uses.

(42) Also shown in FIG. 6A is the stem 1008, which is the portion of the bite plate 1000 that mates with a corresponding socket in the extraoral housing (not shown here). In more detail, a cylindrical shaft 1009 is shown, having a groove into which a jump ring 1010 fits, and mates with a corresponding depression in the socket. Optional flare 1112 is also shown, and is configured to provide an appropriate surface so that the user can push the stem into the socket.

(43) FIG. 6B shows the inner core of the bite plate, typically made from a resin, such as polycarbonate, metal or ceramic having a harder durometer than the outer surface, and providing sufficient rigidity to the stem 1008 so as to allow it to lockingly fit into the socket. In FIG. 6B, the cylindrical shaft has a groove, into which jump ring or circular coil spring fits. The connector can also having locking pins and/or orientation pins to prevent the bite plate from being inserted upside down. Generally, plastics of at least 40 Shore D are used for the core, but metals or ceramics could also be used. A coating is provided over this core, and provides the final shape of the bite plate, as shown in FIG. 6A. Such coating should be a biocompatible soft polymer of 40-70 Shore A, and particularly preferred is a medical grade, clear silicone.

(44) In addition, it is preferred that the bite plate have a connector that is completely compatible with existing drivers, being of the same size and proportions. Using similar connectors allows the bite plates to be interchangeable, and also allows any bite plate inventory to be used even when the driver unit model is updated. Thus, these sizes are valuable for interchangeability of parts. The minimum for interchangeable parts based on the current models requires the cylindrical post to be about 10.25 mm in length and about 6.35 mm in diameter mm with a groove about 4 mm from the attached end of the post.

(45) The connector in FIG. 6 has a flat surface opposite the bite plate, from which protrudes a centrally positioned cylindrical post that is 6-7 (6.35+0.03, 0.1 tolerances indicated) mm in diameter, 10-11 (10.25) mm in length, and having a groove circumventing the post about half way (4 mm from flat surface, with width of 1.65 mm).

(46) The bottom of the post also has a pair of 1.43 mm pins (optional) projecting 180 from each other (in the same plane as the occlusal contacting base of the bite plate). These pins have a total spread of 11.30 mm at the topmost edge, but flare 10 on each side (20 total) to reach the flat surface of the base. The pins are 1.63 mm thick, and 2.75 mm high.

(47) The base of the connector also preferably has a pair of recessions 1.5 mm wide3 mm long2 mm deep (1.583.272.5 mm) on the flat surface thereof for engaging clips from the driver, the recessions being about 16-17 mm apart (22.89 mm in spread), and positioned right below the pins. The recessions can be omitted however, if the base is either not flared or is otherwise smaller, such that the remaining post and pins still fit, leaving the engaging clips on the driver free. These dimensions are approximate, and exact dimensions are provided on FIG. 6.

Markers and Biomarkers

(48) FIG. 7-16 shows various markers and biomarkers that can be used with the diagnostic mouthpads of the invention. Any one or more of the indicated diagnostic indicators can be used herein, preferably, at least 2, 3, 4, 5, 6, 7, 8, 9, 10 diagnostic indicators are used. Obviously, different diagnostic indicators will be selected based on the ease of detection, and the degree of correlation with a disease or predisposition for disease.

(49) We will perform our initial prototyping experiments with markers/biomarkers for oral disease, as these are likely to be of the most immediate interest to dental and orthodontic practitioners. GUSB (-glucuronidase), for example, can be tested using the substrate phenolphthalein mono--glucuronic acid, wherein the product is phenolphthalein (pink above pH 8.2). See U.S. Pat. No. 6,063,588, U.S. Pat. No. 6,277,587.

(50) This can be combined, e.g., with a test strip for e.g., autoinducer 2 (a furanosyl borate diester). Autoinducer 2 can be detected, e.g., with a bioassay using a bacterium which recognizes an autoinducer followed by emitting light, and bacterium such as Vibrio harveyi can be spray dried onto the pad for such tests. See e.g., US20120015397, US20120276546, US20100233742. Alternatively, both spot tests and lateral flow tests for 3-glucuronidase can be tested in a prototype device.

(51) Another oral test that is of importance to dental practitioners is one for oral cancer. Therefore, GNAl2 (Guanine Nucleotide-Binding Protein, Alpha-Inhibiting Activity Polypeptide 2) or IFITM3 (Interferon-Induced Transmembrane Protein 3), as examples, may also be tested in the prototype devices. See e.g., US20110236314. Human biomarkers herein are preferably referred to by their HGNC Approved Gene Symbol, but alternative nomenclature can be found at OMIM.org.

(52) Another oral test that may be of importance to parents and employers is one for drugs of abuse or alcohol. Additionally, monitoring of patient compliance with therapeutic drugs can also be tested. FIG. 16 lists the drugs of abuse and therapeutic drugs that are commonly tested for using saliva. Both the drugs and their metabolite can serve as markers.

(53) Each of the following are incorporated by reference herein in their entireties: US2008227046, US2008227047, US2010055634, US20120322018, US20120040300, US20130059263, 61/624,242 (Apr. 13, 2012), 61/757,288 (Jan. 28, 2013) 61/615,480 (Sep. 14, 2012), 61/673,236 (Jul. 18, 2012); 61/701,532 (Sep. 14, 2012); 61/824,798 (May 17, 2013); 61/837,021 (Jun. 19, 2013). U.S. Pat. No. 6,648,639, U.S. Pat. No. 6,832,912, U.S. Pat. No. 7,029,276 WO1998029746, US20110236314, US20120322086, US20130022961, US20130017559, US20130022969, U.S. Pat. No. 5,770,460, U.S. Pat. No. 5,798,273, U.S. Pat. No. 6,399,295, U.S. Pat. No. 6,656,744, U.S. Pat. No. 7,344,893, U.S. Pat. No. 7,605,004, U.S. Pat. No. 8,377,643, U.S. Pat. No. 8,377,710. Bretz W. A., et al., Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population, J Am Geriatr Soc. 53(9):1532-7 (2005). Hart, T. C., Microbial and Proteomic Biomarkers in Early Childhood Caries, Intl. J. Dentistry 2011, Article ID 196721, (20111). Kau, et al., The clinical evaluation of a novel cyclical force generating device in orthodontics, Orthodontic Practice 1(1) (2010). Kaufman, E., et al., The Diagnostic Applications of SalivaA Review, Crit. Rev. Oral Biol. Med. 13(2) 2002. Nordlund, A., et al., Improved ability of biological and previous caries multimarkers to predict caries disease as revealed by multivariate PLS modelling, BMC Oral Health 9:28 (2009). Pedersen A. N. M., et al., Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjgren's syndrome, BMC Clinical Pathology 5:4 1472-6890-5-4 (2005) Rathnayake N., et al., Salivary Biomarkers for Detection of Systemic Diseases, PLoS One. 8(4) (2013). Ruhl S., The scientific exploration of saliva in the post-proteomic era: from database back to basic function, Expert Rev Proteomics. 9(1):85-96 (2012). Soo, D., et al., The use of salivary biomarkers in occupational and environmental medicine, Occup Environ Med. 64(3): 202-210 (2007). US20080183101; US20090047667; US20100196941; US20100233742, US20100210023; US20120028261; US20120276546; US20130065769; WO2007081306; U.S. Pat. No. 6,063,588; U.S. Pat. No. 6,372,513.

(54) While the invention is described above in detail, it should be understood that various changes, substitutions, and alterations can be made without departing from the spirit and scope of the invention as defined by the following claims. Those skilled in the art may be able to study the preferred embodiments and identify other ways to practice the invention that are not exactly as described herein. It is the intent of the inventors that variations and equivalents of the invention are within the scope of the claims while the description, abstract and drawings are not to be used to limit the scope of the invention. The invention is specifically intended to be as broad as the claims below and their equivalents.